Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Editor's note: this interview was originally published on BioPharmInternational.com.

Shanghai, July 31, 2017: STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development ...

insights from industrySree VadlamudiVice President, Head of Business Development EU, RoWIktos As part of our SLAS Europe 2022 coverage, we speak to Dr. Sree Vadlamudi, Vice President BD at Iktos, ...

The CPHI Pharma Awards 2025 shortlist highlights advancements in synthetic biology, AI, patient access, and sustainable packaging, reflecting evolving industry priorities. The awards emphasize ...

A new technology platform for testing drugs will simplify the process and bring long-term benefits to the pharmaceutical industry. A new technology platform for testing drugs will simplify the process ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Livzon Pharmaceutical Group has ...

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery ...

GEORGETOWN, Texas & SOMERSET, N.J.–(BUSINESS WIRE)–August 2, 2021– DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and ...

BUFFALO, N.Y. -- Gayle A. Brazeau, associate dean for academic affairs in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, has been appointed to a three-year term as an ...